Yevgeniy Samyshkin

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Pulmonary Arterial Hypertension

Electronic Health Record

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

Expert review of hematology

ClinicoEconomics and outcomes research : CEOR

Pulmonary circulation

GSK

Imperial College Business School (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GSK Jan 12 2015

United Kingdom

Director, Value Evidence Analytics :: R&D, Global Medical

IMS Health Ltd Jan 23 2006 - Jan 09 2015

United Kingdom

Director, HEOR and RWE :: HEOR & Real-Worls Evidence

Imperial College Business School

United Kingdom

Research Associate

ABT Associates Inc

Kazakhstan

System Analyst/Health insurance specialist :: Regiona Office in Central Asia

Education History

Imperial College Business School Sep 25 2000

United Kingdom

MSC

Publications

Domenica Lorusso, Holly Guy, Yevgeniy Samyshkin, Carol Hawkes, Kasey Estenson, Robert L Coleman
Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer. Cancers 14 (5) (2022)
Andreas Nikolaou, Apoorva Ambavane, Anshul Shah, Wenkang Ma, Jon Tosh, Venediktos Kapetanakis, Jenny Willson, Feng Wang, Cosmina S Hogea, Boris Gorsh, Ben Gutierrez, Sandhya Sapra, Attaya Suvannasankha, Yevgeniy Samyshkin
Belantamab mafodotin for the treatment of relapsed/refractory multiple myeloma in heavily pretreated patients: a US cost-effectiveness analysis. Expert review of hematology (2021)
Anshul Shah, Jonathan C Tosh, Apoorva Ambavane, Andreas Nikolaou, Cosmina Hogea, Yevgeniy Samyshkin, Boris Gorsh, Eric M Maiese, Feng Wang
Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States. ClinicoEconomics and outcomes research : CEOR 13 (2021)
David G Kiely, Orla Doyle, Edmund Drage, Harvey Jenner, Valentina Salvatelli, Flora A Daniels, John Rigg, Claude Schmitt, Yevgeniy Samyshkin, Allan Lawrie, Rito Bergemann
Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension. Pulmonary circulation 9 (4) (2019)